You are here: All Products  > Innovent Starts Phase II Trial of CTLA-4 mAb for Cervical Cancer

Innovent Starts Phase II Trial of CTLA-4 mAb for Cervical Cancer

Price: $5.00
Available

Get instant access to this article for unlimited viewing and/or downloading for seven days.


Back to products